Legend
Baseline data, acute complications and risk of re-exposure in 10 participating trial groups. Data are n, median (IQR), %(n/N), unless indicated otherwise.
*Number of re-exposed patients with data on second AAP.
Note: BCP refers to percentage with B-cell precursor acute lymphoblastic leukemia, the remaining group had T-cell leukemia.
Abbreviations: AAP, asparaginase-associated pancreatitis; IQR, interquartile range (25 th /75 th centiles); BCP ALL, B-cell precursor acute lymphoblastic leukemia; WBC, white blood cell count. Discordant sex in geno and phenotypes (n total =113; n cases = 34; n controls =79) Individuals missing >10% of variants (n total =81; n cases =15; n controls =66) Excess heterozygosity (n total =20; n cases = 5; n controls =15) Relatedness between individuals (n total =97; n cases = 7; n controls =90)
variants 1584 individuals (250 cases 1334 controls)

SNPs missing in >2% of individuals
(n variants =302644) Not in HW equlibrium (n variants =1909) Minor allele frequency (n variants =898665) Difference in call rate between cases and controls (n variants =6) Duplicated variants (n variants =26567) -Individuals missing >3% of variants (n total =20; n cases =6; n controls =14)
Study cohort 1401908 variants 1564 individuals (244 cases 1320 controls)
Multidimensional scaling plots of genetic ancestry in study population
Legend
Multidimensional scaling plots plot of genetic ancestry of AAP cases, controls and HAPMAP controls for reference. Abbreviations: CEU, Utah residents with Northern and Western European ancestry; CHB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; YRI, Yoruba in Ibadan, Nigeria.
Supplemental figure 4
Quartile-quartile plot
Legend
Quartile-quartile plot showing the expected vs the observed p-values in the cohort of 244 cases and 1320 controls. The logistic regression analysis was adjusted for age and genetic ancestry, with a lambda of 1.02 there was no evidence of population substructure. Oncology, 2016). The trial included 3058 patients, out of which genotyping data was available in 76 cases diagnosed using National Cancer Institute's Common Terminology Criteria for Adverse Events, and 2577 controls. The cohort was included, in the only other GWAS published on pancreatitis in children with ALL 1 . The AALL0232 cohort was genotyped on the Affymetrix Genome-Wide Human SNP 6.0 (or GeneChip Human Mapping 500K) Array, and linkage disequilibrium (LD) between SNPs in the investigation and validation study was assessed by the National Cancer Institute LDassoc tool.
Description of validation cohort
Replication of results in the Children's Oncology Group AALL0232 cohort
Diagnostic criteria for pancreatitis
National Cancer Institute's Common Terminology Criteria for Adverse Events for Pancreatitis 
Association analysis
Time-dependent analysis (Cox proportional hazards regression) was performed adjusting for age and ancestry.
Legend
The Abbreviations: ASP, asparaginase; PEG, pegylated; BSA, body surface area; NSAA, nadir serum asparaginase activity.
Baseline data in 318 patients included in the Dana Farber Cancer Institute cohort
Association analysis
Binary logistic regression analysis was performed adjusting for age.
Legend
The Legend Genotype of rs62228256. The table shows the rs62228256 genotype in cases with pancreatitis and controls without pancreatitis.
Regional association plot of the PRSS1 and PRSS2 loci on chromosome 7 in AALL0232
Regional asssociation plot showing SNPs associated with asparaginase-associated pancreatitis in 76 cases and 2570 controls. The x axis represents genomic location, and the y axis represents the P value for the SNP's association calculated using logistic regression adjusting for age and ancestry. The color of the dots reflects the linkage disequilibrium of the genotyped SNPs and rs13228878. LD is based on 1000 genomes European CEU samples, November 2014. The human assembly GRCh37 was used for reference.
Multidimensional scaling plots of genetic ancestry from CEU cohort
Legend
Multidimensional scaling plots plot of genetic ancestry in AAP cases and controls from the CEU population. Defined as individuals >16 standard deviations away from the HapMap-defined CEU (Northern and Western European) centroid mean.
Quartile-quartile plot of CEU cohort Legend
Quartile-quartile plot showing the expected vs the observed p-values in the CEU cohort of 205 cases and 1185 controls. The logistic regression analysis was adjusted for age and genetic ancestry, with a lambda of 1.02 there was no evidence of population substructure.
Supplemental figure 8
Manhattanplot of CEU cohort
Legend
Manhattanplot showing SNPs associated with asparaginase-associated pancreatitis in 205 cases and 1185 controls in the CEU cohort. The x axis represents genomic location, and the y axis represents the P value for the SNP's association calculated using logistic regression adjusting for age and ancestry. Genes previously associated to pancreatitis are marked in color. SNPs are annotated to genes based on genomic location (10 kb up-and downstream from transcription start site and transcription terminator, respectively. The human assembly GRCh37 was used for Supplemental table 2 Top SNPs in genes previously associated with risk of pancreatitis in CEU cohort with chymotrypsin-like protease activity, regulating activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors); PRSS1-2, protease, serine, 2 (encoding for cationic and anionic trypsinogen); SPINK1, serine peptidase inhibitor, kazal type 1 (Prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct).
Supplemental table 3
Top SNPs in genes previously associated with risk of pancreatitis in the total cohort 
Legend
Top-five SNPs associated with asparaginase-associated pancreatitis in 244 cases and 1320 controls. SNPs were annotated to genes if ≤10kb upstream or downstream from transcription start site or transcription terminator, respectively. SNPs and genes were identified from litterature search (see methods section), genefunctions are defined by Genecards (www.genecards.org) and UniPort (www.uniprot.org).
Abbreviations: SNP, single nucleotide polymorphism; Chr, chromosome; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval; CASR, calcium-sensing receptor (G protein-coupled receptor, small changes in circulating calcium concentration are monitored affecting intracellular signaling pathways); CFTR, cystic fibrosis transmembrane conductance regulator (cAMP-regulated cell channel, conducting chloride and thiocyanate ions across epithelial membranes); CLDN2, claudin-2 (Major integral membrane protein localized exclusively at tight junctions); CPA1: Carboxypeptidase A1
(Member of the serine protease family, A1 form of the pancreatic procarboxypeptidase produced in pancreatic acinar cells, preferentially cleaves C-terminal branched-chain and aromatic amino acids from dietary proteins); CTRB1-2, chymotrypsin B1-B2 (member of the serine protease family of enzymes, regulating activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors); CTRC: chymotrypsin C (serum calcium-decreasing factor with chymotrypsin-like protease activity, regulating activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors); PRSS1-2, protease, serine, 2 (encoding for cationic and anionic trypsinogen); SPINK1, serine peptidase inhibitor, kazal type 1 (Prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct).
